What % of your PCIs are intravascular-imaging guided? @DrBillLombardi @KateKearney4 @jamiemccabeMD @DavidElison1 @ZLSteinberg @CJChungMD

🚀 In a large #CHIP #PCI center @UWMedHeart, systematic intravascular imaging (≥80% of PCIs) led to 📉 radiation dose, 📉 contrast volume, and 📉 cardiac tamponade rates. Strong evidence for systematic IVI use! 💪 @LAzzaliniMD https://t.co/mnHGZPk4nb

5- Finally, the best data that stuck with me and probably will affect my practice Outcomes presented by Taishi Hirai, led by @grantham_aaron. Bringing pt back after STAR at 5-7 weeks had numerically higher success rates compared with 12-14 weeks. My default was 8 weeks, and I

Predicting hemodynamics collapse requiring bailout #MCS: the holy grail of #PCI. Interesting data presented at @crfheart #CTO2025 by rising 🌟 @enricopoletti4: identifying these pts is paramount to adopt preventive strategies (bailout MCS outcomes are very poor). @UWMedHeart

Excited to share our PURPOSE study on the Trilogy JenaValve system for aortic regurgitation. ➡️ Higher success: lower THV embolization, second valve, and residual AR. JVT offers hope for inoperable AR patients. #JACCJournals #TAVR #JenaValve #AorticRegurgitation

Thanks to all centers who participated (@AngeloQuagliana, @FlavioRibichini ) And as always proud of our team (@enricopoletti4 , @EdgardPrihadi)!

https://t.co/8rmF8VEPUZ Please enjoy our editorial on 2 relevant papers from the group of @esbrilakis (the #PROGRESS registry) assessing pro and contra of #ADR and #retro techniques in #CTO #PCI. Thanks to @enricopoletti4 and Carlo Zivelonghi.

💥Check out the results of our in-vitro validation of coronary physiology assessment with 5F guiding catheter! 🔬 🎯great level of agreement with 6F guiding catheter 🎯very high reproducibility #FullPhysiology #CoronaryPhysiology https://t.co/nTBKsa26RI

Bravo @LMarcon111

The Progress-AF study: 🎯 dynamic changes of LA substrate over time following PVI 👉Regression occurs with ⬇️ #AFib burden 👉Progression occurs with persistent AF 📖  https://t.co/I9xQLKWgP9  @ESC_Journals @GiulioConte9 @Dominik_Linz @FraSantoroMD @AndyZhangMD @marcovitoloMD

Unveiling latest-gen TAVR performance in pure severe native aortic valve regurgitation. Just released in @JACCJournals, the PANTHEON study focuses on cutting-edge THV platforms in this specific scenario. #JACCINT #CardioTwitter #TAVR

Amazing experience at #EuroPCR 2023 🇫🇷! Great sessions and good time with many colleagues and friends! Thanks to #HartCentrum #ZNA team ❤️ @AgostoniPF @GCastaldi_90 @enricopoletti4 Alice Moroni Giovanni Vescovo Andrea Bezzeccheri